Starting in 2026, Californians will be able to buy prescription insulin pens for $11. Through CalRx and a partnership with manufacturers, Californians will be able to buy discounted insulin from the ...

The settlement resolves allegations that, from 2010 through 2020, CVS violated the False Claims Act in connection with its billing and dispensing of insulin pens to patients enrolled in government ...

CVS Pharmacy agreed to pay $37.7 million to settle a lawsuit with the United States over a decade-long practice of over-dispensing insulin to customers and then seeking undue reimbursements from ...

CVS reached a settlement on Tuesday with the U.S. Attorney for the Southern District of New York for over $37.75 million after the retailer was accused of over-dispensing insulin pens to patients.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min According to the DOJ, CVS ...

CVS Pharmacy will pay $37.76 million to resolve allegations that it over-dispensed insulin pens and improperly billed federal health programs over a 10-year period. The settlement resolves claims that ...

CVS has agreed to pay almost $38 million to settle allegations that its pharmacies overcharged the government for insulin pens over a decade, putting to bed a Department of Justice lawsuit and several ...

NEW YORK, Dec 2 (Reuters) - CVS Health (CVS.N), opens new tab will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements ...

CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and improperly billed federal healthcare programs for those insulin prescriptions. The ...